Advancing Cancer Research
& Treatment for Patients
Around the Globe.
Upcoming CR&T Events:
International Patient Symposium on
Myeloproliferative Neoplasms (MPNs)
and
Cancer Survivors Hall of Fame Dinner
Cancer Research & Treatment Fund (CR&T) is proud to host two events each Fall.
More information is available on the MPN Symposium and on the Hall of Fame tab.
About the CR&T
Who We Are
In 1968, Richard T. Silver, MD, a prominent hematologist-oncologist, founded the Cancer Research & Treatment Fund (CR&T) with the belief that investing in blood cancer research would lead to important breakthroughs, as well as a better understanding of the biology and treatment of all forms of cancer. While the focus of the organization is the myeloproliferative neoplasms (MPNs), over the course of its 56-year history, CR&T has awarded more than $17 million in grants to research that has contributed to major advances in the fight against cancer.
BLOOD CANCER
RESEARCH
THE DR. RICHARD
T. SILVER CHAIR
FOR OTHER
CANCER RESEARCH
CR&T Gallery
Medical Advisory Board
At CR&T, our activities and funding objectives are guided by the expertise of a world-class Medical Advisory Board, featuring some of the world’s foremost physician-scientists in cancer treatment research.
Your gift today can help change a cancer patient's life.
More Ways to Give